In addition, SIRT1-AMPK-PGC-1α pathway exerts its anti-oxidative activity in other diabetic vascular complications including brain complications (56), diabetic cardiomyopathy, and diabetic nephropathy (57, 58). This evidence concerns the gene SIRT1 and diabetic kidney disease.